staceywhite, Author at European Medical Journal - Page 50 of 195

Updates in BRAF V600E-Mutated Metastatic Colorectal Cancer

Chiara Cremolini and Julien Taieb discuss the most important updates in BRAF V600E-mutated metastatic colorectal cancer (mCRC) research…

Follow-Up Care Models Post-Cancer Treatment

After being diagnosed with cancer, patients embark on a journey that involves ongoing treatments, and regular visits to healthcare…

Staphylococcus aureus Bacteraemia and CKD

Patients with chronic kidney disease (CKD), especially those on chronic haemodialysis (HD), have a higher incidence of nosocomial…

IgD Multiple Myeloma

Multiple myeloma (MM) is a disease characterised by the clonal expansion of malignant plasma cells in the marrow, leading to anaemia…

Sickle Cell Thalassaemia and Overlapping Syndrome

Sickle cell disease (SCD) is a genetic condition caused by mutations in the haemoglobin (Hb) gene, resulting in various complications. One…

Review of the European Association for Haemophilia and Allied Disorders (EAHAD) Annual Congress 2024

The congress featured an enthusiastic welcome from 2024 EAHAD Congress President, Wolfgang Miesbach, who discussed the ongoing innovation…

Optimising Outcomes of Haemophilia Treatment

The 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) took place in Frankfurt, Germany, from…

Navigating Adjuvant Melanoma Treatment Choices

Navigating Adjuvant Melanoma Treatment Choices – The typical patient for whom adjuvant therapy may be considered, and provide details on…

Should Coronary Artery Fistula Be Treated?

Coronary artery fistulas (CAF) are communications between a coronary artery and a major vessel or a cardiac chamber.1 More than 90% of…

Contraceptive Use Among Females with HIV

HIV is an epidemic in Kenya. Females living with HIV (FLHIV) have an eight-fold increased risk of a pregnancy-related death compared to…